The GHRH and Secretagogue Pair combines CJC-1295 No DAC with Ipamorelin, acting at two separate points in the somatotropic axis. Pituitary cell models often use both to separate GHRH receptor activity from ghrelin receptor activity.
- CJC-1295 No DAC 10mg vial, a tetra-substituted analogue of GHRH (1-29)
- Ipamorelin 10mg vial, a selective pentapeptide agonist at the ghrelin receptor GHS-R1a
GHRH and Secretagogue Pair research applications
- cAMP accumulation in cultured pituitary somatotrophs, the GHRH receptor readout for CJC-1295 No DAC
- Calcium mobilisation and IP-One accumulation in GHS-R1a expressing HEK293 or CHO lines, the Ipamorelin readout
- Growth hormone in conditioned medium by ELISA, with each peptide alone and the two side by side
Research profiles: CJC-1295 and Ipamorelin
What is tested in this pair
This pair contains two products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| CJC-1295 No DAC | 99.46% | Janoshik Analytical | 9 Jul 2026 | View |
| Ipamorelin | 99.71% | Janoshik Analytical | 9 Jul 2026 | View |







